Table 1.
SCARNA12 Expression | |||||
---|---|---|---|---|---|
characteristics | case | Low | High | χ2 | P |
Sex | 0.013 | 0.910 | |||
Female | 157 | 78 | 79 | ||
Male | 157 | 79 | 78 | ||
Age(year) | 0.116 | 0.733 | |||
≤ 70 | 175 | 89 | 86 | ||
> 70 | 139 | 68 | 71 | ||
TNM stage(AJCC) | 0.052 | 0.820 | |||
Stage I/II | 178 | 88 | 90 | ||
Stage III/IV | 136 | 69 | 67 | ||
Pathological T category | 0.183 | 0.669 | |||
T1/T2 | 61 | 32 | 29 | ||
T3/T4 | 253 | 125 | 128 | ||
Lymph node metastasis | 0.117 | 0.732 | |||
Negative | 181 | 89 | 92 | ||
Positive | 133 | 68 | 65 | ||
Distant metastasis | 0.211 | 0.646 | |||
Negative | 263 | 133 | 130 | ||
Positive | 51 | 24 | 27 | ||
Lymphatic invasion | 3.007 | 0.083 | |||
Negative | 191 | 103 | 88 | ||
Positive | 123 | 54 | 69 | ||
Venous invasion | 0.017 | 0.897 | |||
Negative | 233 | 117 | 116 | ||
Positive | 81 | 40 | 41 | ||
History of colon polyps | 11.504 | < 0.001 | |||
Negative | 214 | 121 | 93 | ||
Positive | 100 | 36 | 64 |
Cutoff threshold of SCARNA12 expression is median value in all patients in this cohort
Abbreviations: AJCC American Joint Committee on cancer